Can myeloproliferative neoplasms cause acute myeloid leukaemia?

Transformation is not inevitable. Its significance and the individual concern depend on the type of myeloproliferative neoplasm, changes in blood counts, bone marrow findings, genetic features, previous treatment and overall health.

Myeloproliferative neoplasms begin in blood-forming stem cells and can remain in a chronic phase. If the abnormal cell population acquires further changes, immature cells called blasts may build up in the bone marrow and blood. When the findings meet diagnostic criteria for acute myeloid leukaemia, the disease is described as having transformed.

Fewer healthy red cells, infection-fighting white cells and platelets may then be produced. This can lead to worsening fatigue, breathlessness, infections, fever, bruising or bleeding, although symptoms alone cannot diagnose transformation.

Attend planned haematology reviews and blood counts, even when you feel well. Contact the team between visits if symptoms change. A new blood-count pattern may lead to examination of a blood film, bone marrow testing and molecular or chromosome tests.

If transformation is confirmed, a specialist team considers the disease features, current fitness, other medical conditions and your priorities. The plan may include medicines that target leukaemia cells, supportive transfusions or infection care, and assessment for a stem cell transplant when appropriate.

Request prompt advice for a new fever, recurrent infections, rapidly increasing tiredness, unexplained breathlessness, new bruises, pinpoint red or purple spots, gum or nose bleeding, or unintended weight loss. Get urgent help for severe breathlessness, heavy or persistent bleeding, fainting, confusion or chest pain.

Ask what your recent blood-count trend shows, whether blasts have been seen, what further tests would clarify a change, which symptoms require same-day contact and how your present treatment affects the monitoring plan.